Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone, supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compound: Semax. Sequence: Met-Glu-His-Phe-Pro-Gly-Pro. Format: lyophilised powder. Quantity: 5mg per vial. Purity: 98% minimum, analytically verified. Appearance: white lyophilised powder. Molecular weight: approximately 813.9 g/mol. CAS number: 80714-61-0. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - Semax is a synthetic analogue of the ACTH 4-10 fragment, modified with a C-terminal Pro-Gly-Pro extension intended to improve stability against enzymatic degradation. Because the parent fragment lacks the hormonal activity of full-length ACTH, laboratory interest centres instead on neuropeptide research: expression of neurotrophic factors in cultured neuronal models, comparative stability against the unmodified ACTH 4-10 sequence, and behaviour in blood-brain barrier permeability studies. Genesis Peptides supplies Semax in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.